Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J of Med 292:344–347

Article  CAS  Google Scholar 

Lundberg IE, Tjärnlund A, Bottai M et al (2017) 2017 European league against rheumatism/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468

Article  PubMed  Google Scholar 

Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG (2014) The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep 16(12):467. https://doi.org/10.1007/s11926-014-0467-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boulman N, Slobodin G, Rozenbaum M, Rosner I (2005) Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34(6):805–812. https://doi.org/10.1016/j.semarthrit.2005.01.016

Article  PubMed  Google Scholar 

Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A (2018) Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools. Front Immunol 9:2951. https://doi.org/10.3389/fimmu.2018.02951

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung MP, Richardson C, Kirakossian D et al (2020) Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmune Rev 19(6):102533. https://doi.org/10.1016/j.autrev.2020.102533

Article  CAS  Google Scholar 

Orandi AB, Dharnidharka VR, Al-Hammadi N, Baszis KW (2018) CARRA legacy registry investigators. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatr Rheumatol Online J 16(1):84. https://doi.org/10.1186/s12969-018-0299-9

Article  PubMed  PubMed Central  Google Scholar 

Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP (2002) Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 47(4):505–511. https://doi.org/10.1067/mjd.2002.12219

Article  PubMed  Google Scholar 

Tansley SL, Betteridge ZE, Shaddick G et al (2014) Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 53(12):2204–2208. https://doi.org/10.1093/rheumatology/keu259

Article  PubMed  Google Scholar 

Phillippi K, Hoeltzel M, Byun Robinson A, Kim S (2017) Childhood arthritis and rheumatology research alliance (CARRA) legacy registry investigators. Race, income, and disease outcomes in juvenile dermatomyositis. J Pediatr 184:38-44.e1. https://doi.org/10.1016/j.jpeds.2017.01.046

Article  PubMed  PubMed Central  Google Scholar 

Pachman LM, Abbott K, Sinacore JM et al (2006) Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 148(2):247–253. https://doi.org/10.1016/j.jpeds.2005.10.032

Article  PubMed  Google Scholar 

Mathiesen PR, Zak M, Herlin T, Nielsen SM (2010) Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol 28(5):782–789

CAS  PubMed  Google Scholar 

Davis WR, Halls JE, Offiah AC, Pilkington C, Owens CM, Rosendahl K (2011) Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system. Rheumatology (Oxford) 50(12):2237–2244. https://doi.org/10.1093/rheumatology/ker262

Article  PubMed  Google Scholar 

Thyoka M, Adekunle O, Pilkington C et al (2018) Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. Rheumatology (Oxford) 57(9):1661–1668. https://doi.org/10.1093/rheumatology/key144

Article  CAS  PubMed  Google Scholar 

Kimball AB, Summers RM, Turner M et al (2000) Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis Implications for diagnosis and therapy. Arthritis Rheum 43(8):1866–1873. https://doi.org/10.1002/1529-0131(200008)43:8%3c1866::AID-ANR24%3e3.0.CO;2-6

Article  CAS  PubMed  Google Scholar 

Faller G, Mistry BJ, Tikly M (2014) Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J 12:2. https://doi.org/10.1186/1546-0096-12-2

Article  PubMed  PubMed Central  Google Scholar 

Tabarki B, Ponsot G, Prieur AM, Tardieu M (1998) Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. Eur J Paediatr Neurol 2(4):205–211. https://doi.org/10.1016/s1090-3798(98)80021-4

Article  CAS  PubMed  Google Scholar 

Rider LG, Shah M, Mamyrova G et al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92(4):223–243. https://doi.org/10.1097/MD.0b013e31829d08f9

Article  CAS  PubMed  Google Scholar 

Tansley SL, Simou S, Shaddick G et al (2017) Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun 84:55–64. https://doi.org/10.1016/j.jaut.2017.06.007

Article  CAS  PubMed  PubMed Central  Google Scholar